AI systems are evolving to remember past interactions and provide continuous assistance. This shift challenges AI to move ...
In its 2026 Fleet Benchmark Report, Fleetio analyzed data from 1.2 million vehicles, 17.5 billion miles, $7 billion in ...
The European Commission has approved Ranluspec, a ranibizumab biosimilar developed by Lupin and commercialized by Sandoz, for the treatment of neovascular age-related macular degeneration and several ...